Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.82 USD | +1.68% | +2.82% | -4.21% |
Apr. 18 | Verastem Names John Hayslip as Chief Medical Officer | MT |
Apr. 15 | I-Mab Announces Chief Medical Officer Changes | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.21% | 144M | |
+33.43% | 690B | |
+26.43% | 546B | |
-5.12% | 358B | |
+19.59% | 323B | |
+4.89% | 287B | |
+14.32% | 235B | |
+5.79% | 199B | |
-9.49% | 195B | |
+4.26% | 161B |
- Stock Market
- Equities
- IMAB Stock
- News I-Mab
- I-Mab Completes Enrollment in Phase 3 Trial of Eftansomatropin Alfa to Treat Pediatric Growth Hormone Deficiency